{"id": "1356610046805868545", "creation": 1612276014.0, "user_id": "2826292747", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 3, "reply_count": 0, "like_count": 9, "quote_count": 2}}, "text": "Safety and interim clinical efficacy of an rAd26 and rAd5 vector-based #COVID19 #vaccine Gam-COVID-Vac (Sputnik V). A randomised phase 3 trial in Russia. 91\u00b76% efficacy. The vaccine is stored and distributed at \u201318\u00b0C, but storage at 2\u20138\u00b0C https://t.co/2x0UR6GG3R via @TheLancet https://t.co/JbZpIsz5o5", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}